https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Treatment of idiopathic pulmonary fibrosis in Australia and New Zealand: a position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:34064 Wed 04 Sep 2019 10:06:34 AEST ]]> Mitochondrial dysfunction contributes to the senescent phenotype of IPF lung fibroblasts https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:45701 Tue 28 Mar 2023 15:44:53 AEDT ]]> Cryobiopsy for Identification of Usual Interstitial Pneumonia and Other Interstitial Lung Disease Features: Further Lessons from COLDICE, a Prospective Multicenter Clinical Trial https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:41876 Tue 16 Aug 2022 14:17:45 AEST ]]> Biomarker signatures for progressive idiopathic pulmonary fibrosis https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:47057 Tue 13 Dec 2022 15:32:32 AEDT ]]> Implications of the diagnostic criteria of idiopathic pulmonary fibrosis in clinical practice: Analysis from the Australian Idiopathic Pulmonary Fibrosis Registry https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:46906 Tue 06 Dec 2022 16:07:23 AEDT ]]> Activation of the absent in melanoma 2 inflammasome in peripheral blood mononuclear cells from idiopathic pulmonary fibrosis patients leads to the release of pro-fibrotic mediators https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:32030 Thu 28 Oct 2021 13:03:16 AEDT ]]> Regulation of cellular senescence is independent from profibrotic fibroblast-deposited ECM https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:48871 Thu 13 Apr 2023 12:47:57 AEST ]]> Annexin A2 contributes to lung injury and fibrosis by augmenting factor Xa fibrogenic activity https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:34569 Thu 04 Nov 2021 10:38:24 AEDT ]]> Idiopathic pulmonary fibrosis will increase the risk of lung cancer https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:20409 Sat 24 Mar 2018 08:00:51 AEDT ]]> Fibroblast senescence in the pathology of idiopathic pulmonary fibrosis https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:35652 Mon 20 Nov 2023 11:12:20 AEDT ]]> Inhaled pirfenidone solution (AP01) for IPF: A randomised, open-label, dose-response trial https://novaprd-lb.newcastle.edu.au/vital/access/ /manager/Repository/uon:51684 Fri 15 Sep 2023 09:37:14 AEST ]]>